Balyasny Asset Management
TECX

Balyasny Asset Management’s Tectonic Therapeutic TECX Stock Holding History

Balyasny Asset Management’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,192
Closed -$181K – 3467
2025
Q1 		$181K Sell
10,192
-236,808
-96% -$7.72M ﹤0.01% 2608
2024
Q4 		$11.4M Buy
247,000
+66,527
+37% +$2.81M 0.02% 901
2024
Q3 		$5.47M Buy
+180,473
New +$3.3M 0.01% 1218
2022
Q4 		– Sell
-1,118
Closed -$9K – 3308
2022
Q3 		$9K Buy
+1,118
New +$12.4K ﹤0.01% 2657
2020
Q4 		– Sell
-10,375
Closed -$1.62M – 1779
2020
Q3 		$1.62M Buy
+10,375
New +$2.09M 0.01% 890
2020
Q1 		– Sell
-4,957
Closed -$1.2M – 1583
2019
Q4 		$1.2M Buy
+4,957
New +$956K 0.01% 857

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Balyasny Asset Management's TECX Position: Q2 2025 in Review

Balyasny Asset Management sold out of Tectonic Therapeutic (TECX) in Q2 2025, closing a stake of 10,192 shares — an estimated $181K sold.

Balyasny Asset Management first reported a position in TECX in Q4 2019 and held it in 6 quarters. The position peaked at $11.4M in Q4 2024. 82 funds tracked by Wall St. Rank hold TECX as of Q2 2025.

  • Balyasny Asset Management reported no remaining Tectonic Therapeutic position as of Q2 2025 after selling out during the quarter.
  • Balyasny Asset Management sold 10,192 Tectonic Therapeutic shares in Q2 2025, an estimated $181K.
  • Balyasny Asset Management first reported a position in Tectonic Therapeutic in Q4 2019 and held it in 6 quarters.
  • Balyasny Asset Management's Tectonic Therapeutic position peaked at $11.4M in Q4 2024.
  • 82 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2025.

Based on Balyasny Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.